Respiratory Complications After Laparoscopic Surgery

November 19, 2012 updated by: Anne Kathrine Staehr, Herlev Hospital
The purpose of this study is to describe the magnitude of respiratory complications after laparoscopic hysterectomy and cholecystectomy.

Study Overview

Detailed Description

The purpose of this study is to describe change in pulmonary function and incidence of respiratory complications after laparoscopic surgery.

The investigators will include 60 women scheduled for laparoscopic hysterectomy or cholecystectomy. The investigators will measure the pulmonary function by different methods during and for 2 hours after surgery. Moreover, the incidence of respiratory complications including pneumonia, respiratory failure and radiologically verified atelectasis will be registered.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Herlev, Denmark, 2730
        • Department of Anesthesia, Herlev Hospital
      • Hillerød, Denmark, 3400
        • Department of Anesthesia, Hillerød Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Patients scheduled for elective laparoscopic surgery

Description

Inclusion Criteria:

  • Women
  • > 45 years old
  • Scheduled for laparoscopic cholecystectomy or laparoscopic hysterectomy

Exclusion Criteria:

  • Weight < 50 kg
  • Pregnant or nursing
  • Cardiac failure
  • Renal failure
  • Inability to breath through a facial mask
  • Inability to give informed consent
  • Inability to keep arterial oxygen saturation above 90% without supplemental oxygen

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Cholecystectomy
Women scheduled for laparoscopic cholecystectomy
Hysterectomy
Women scheduled for laparoscopic hysterectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arterial oxygen tension 2 hours after surgery
Time Frame: 2 hours after end of surgery
Change in arterial oxygen tension 2 hours after surgery
2 hours after end of surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygenation index 2 hours after surgery
Time Frame: 2 hours after end of surgery
Change in oxygenation index (PaO2/FiO2) 2 hours after surgery
2 hours after end of surgery
FEV1 and FVC 2 hours after surgery
Time Frame: 2 hours after end of surgery
Change in FEV1 and FVC 2 hours after surgery
2 hours after end of surgery
Pulmonary shunt 2 hours after surgery
Time Frame: 2 hours after end of surgery
Change in pulmonary shunt 2 hours after surgery
2 hours after end of surgery
Ventilation-perfusion ratio 2 hours after surgery
Time Frame: 2 hours after end of surgery
Change in ventilation-perfusion ratio from baseline to 2 hours after surgery
2 hours after end of surgery
Arterial oxygen saturation 2 hours after surgery
Time Frame: 2 hours after surgery
Change in arterial oxygen saturation 2 hours after surgery
2 hours after surgery
Respiratory frequency 2 hours after surgery
Time Frame: 2 hours after surgery
Change in respiratory frequency 2 hours after surgery
2 hours after surgery
Oxygen supplement at discharge from the postanesthesia care unit
Time Frame: At discharge from the postanesthesia care unit, which will be approximately 2 hours after surgery
The proportion of patients who received oxygen supplement at discharge from the postanesthesia care unit in order keep arterial oxygen saturation above 93%
At discharge from the postanesthesia care unit, which will be approximately 2 hours after surgery
Connection between pulmonary shunt and need for oxygen supplement
Time Frame: 2 hours postoperatively and at discharge from the postanesthesia care unit
The connection between pulmonary shunt 2 hours after surgery and need for oxygen supplement at discharge from the postanesthesia department in order to keep peripheral oxygen saturation above 93%.
2 hours postoperatively and at discharge from the postanesthesia care unit
FEV1 and FVC 24 hours after surgery
Time Frame: 24 hours after surgery
Change in FEV1 and FVC 24 hours after surgery
24 hours after surgery
Pulmonary shunt 24 hours after surgery
Time Frame: 24 hours after surgery
Change in pulmonary shunt 24 hours after surgery
24 hours after surgery
Ventilation-perfusion ratio 24 hours after surgery
Time Frame: 24 hours after surgery
Change in ventilation-perfusion ratio 24 hours after surgery
24 hours after surgery
Arterial oxygen saturation 24 hours after surgery
Time Frame: 24 hours after surgery
Change in arterial oxygen saturation 24 hours after surgery
24 hours after surgery
Respiratory frequency 24 hours after surgery
Time Frame: 24 hours after surgery
Change in respiratory frequency 24 hours after surgery
24 hours after surgery
Length of stay
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Length of stay at the hospital
Participants will be followed for the duration of hospital stay, an expected average of 3 days
Pneumonia
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Incidence of pneumonia from surgery to discharge from hospital
Participants will be followed for the duration of hospital stay, an expected average of 3 days
Respiratory failure after surgery
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Incidence of respiratory failure from surgery to discharge from hospital
Participants will be followed for the duration of hospital stay, an expected average of 3 days
Atelectasis
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Incidence of radiologically verified atelectasis from surgery to discharge from hospital
Participants will be followed for the duration of hospital stay, an expected average of 3 days
High temperature
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Incidence of a high temperature ( above 38 degrees celsius) from surgery to discharge from hospital
Participants will be followed for the duration of hospital stay, an expected average of 3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Mona R Gätke, M.D. Ph.D., Department of Anesthesia, Herlev Hospital, University of Copenhagen
  • Principal Investigator: Anne K Staehr, M.D., Department of Anesthesia, Herlev Hospital, University of Copenhagen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (Actual)

November 1, 2012

Study Completion (Actual)

November 1, 2012

Study Registration Dates

First Submitted

November 15, 2011

First Submitted That Met QC Criteria

November 21, 2011

First Posted (Estimate)

November 22, 2011

Study Record Updates

Last Update Posted (Estimate)

November 20, 2012

Last Update Submitted That Met QC Criteria

November 19, 2012

Last Verified

November 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

3
Subscribe